It is estimated that nearly 16,500 patients (12,900 men and 3600 women) were diagnosed with esophageal cancer in 2009, with 14,500 dying from the disease. 1 This is a 460% increase in the incidence of esophageal adenocarcinoma for White men and 335% for White women since 1970. In contrast, esophageal squamous cell carcinoma is declining in incidence. In the 1960s, squamous cell carcinoma accounted for nearly 90% of esophageal malignancies. However, adenocarcinoma presently accounts for more than 60% of the new cases. Mortality associated with esophageal cancer is related to the stage of disease at presentation, with 5-year survival rates of 35% for localized disease and 3% for metastatic disease.